Oral MS drug Lemtrada approved by European Commission

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

Oral MS drug Lemtrada approved by European Commission

Postby MSUK » Tue Sep 17, 2013 12:27 am

Genzyme, a Sanofi company announced today that the European Commission has granted marketing authorization for Lemtrada(TM). This follows the August 30th approval of Aubagio(R). The company intends to begin launching both products in the EU soon.

"The approvals of Lemtrada and Aubagio in the European Union represent an important milestone for Genzyme and demonstrate our focus on scientific innovation and commitment to multiple sclerosis patients," said Genzyme CEO and President, David Meeker, M.D. "This is particularly exciting as the EU approval is the first for Lemtrada globally. We look forward to making these unique therapies available to MS patients very soon............" - Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2501
Joined: Wed Oct 14, 2009 2:00 pm


Re: Oral MS drug Lemtrada approved by European Commission

Postby aredmosquito » Sun Sep 22, 2013 8:16 pm

This title is misleading. Lemtrada is an IV infusion, as the stomach would destroy the drug if taken orally.
Diagnosed with RRMS March 2013.
Rebif May 2013 - September 2014.
Gilenya since November 2014.
Getting to Know You...
Posts: 19
Joined: Sun Mar 17, 2013 8:13 am
Location: Southeast WI, USA

Return to Campath (Lemtrada, Alemtuzumab)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service